Associated Papers
Structure of human phagocyte NADPH oxidase in the activated state.
Liu X et al.
Nature, 2024
Structure of the core human NADPH oxidase NOX2.
Noreng S et al.
Nature Communications, 2022
36241643 (PubMed )
Supplement: 41467_2022_33711_MOESM1_ESM.pdf
Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.
Chan KW et al.
Frontiers in Immunology, 2022
Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.
Mollin M et al.
Clinical and Experimental Immunology, 2021
Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease.
Chiu TL et al.
Frontiers in Immunology, 2021
Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
Wolach B et al.
Journal of Clinical Immunology, 2011
Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.
Ryu GM et al.
Nucleic Acids Research, 2009
19139070 (PubMed )
Supplement: gkn1008_nar-01723-s-2008-File009.xls › TypeII_
[The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation].
Stasia MJ
Medecine Sciences : M/s, 2007
Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly.
Li XJ et al.
Journal of Leukocyte Biology, 2007
Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
Bionda C et al.
Human Genetics, 2004
[Chronic granulomatous disease (CGD)].
Takikawa K et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine, 1977
Select a paper to view details